Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Goserelin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for goserelin acetate and what is the scope of goserelin acetate freedom to operate?

Goserelin acetate
is the generic ingredient in one branded drug marketed by Astrazeneca and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Goserelin acetate has forty-seven patent family members in thirty-three countries.

There are three drug master file entries for goserelin acetate. Two suppliers are listed for this compound.

Summary for Generic Name: goserelin acetate

Tradenames:1
Patents:3
Applicants:1
NDAs:2
Drug Master File Entries: see list3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list22
Clinical Trials: see list481
Patent Applications: see list6,133
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:goserelin acetate at DailyMed

Pharmacology for Ingredient: goserelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes7,500,964► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes7,220,247► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes7,118,552► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes7,118,552► SubscribeY ► Subscribe
Astrazeneca
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes7,220,247► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot